Brief: Impel Neuropharma Inc Shares Open 2.1% Above IPO Price In Nasdaq Debut
23/04/2021 16:48
April 23 (Reuters) -
* IMPEL NEUROPHARMA INC SHARES OPEN AT $15.31 IN NASDAQ
DEBUT
VERSUS IPO PRICE OF $15.00/SHARE
Further company coverage: IMPL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on IPI Legacy Liquidation Co
See all newsBrief: Impel Pharmaceuticals- On Dec 19, 2023, Co And Impel NeuroPharma Australia Commenced Voluntary Chapter 11 Proceedings
Brief: Impel Pharmaceuticals Says On Dec 1 Michael Kalb Gave Notice Of Resignation From Position As CFO With Last Day To Be December 31
U.S. STOCKS ON THE MOVE-iRobot Corp, Faraday Future, Fisker
U.S. STOCKS ON THE MOVE-iRobot Corp, Fisker Inc, International Seaways Inc
Brief: Impel Pharmaceuticals Receives Delisting Notice From Nasdaq